Liposome-Encapsulated Botulinum Toxin A in Treatment of Functional Bladder Disorders
Botulinum toxin A (BoNT-A) intravesical injections have been used to treat patients with refractory functional bladder disorders such as overactive bladder (OAB) and interstitial cystitis/bladder pain syndrome (IC/BPS), but the risk of adverse events and the need for repeated injections continue to...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2022-12-01
|
| Col·lecció: | Toxins |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2072-6651/14/12/838 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|